Metamizole Safety In Spotlight As EMA Tackles Pregnancy/Lactation Labeling Disarray

04 Jun 2018

More than 50 metamizole-containing medicines are being reviewed by the European Medicines Agency because of substantial differences in their national product labeling regarding dosage and contraindications in pregnant and breastfeeding women.

Spotlight — The dosage and use of metamizole is under spotlight in the EU

Metamizole Safety In Spotlight As EMA Tackles Pregnancy/Lactation Labeling Disarray

More from Drug Safety

More from Pink Sheet